ResearcherCancer Research UK Scotland InstituteActive in the last 2 years

Hannah Mearns

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8581-1288; OpenAlex author ID A5060822052. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.70213 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sara R. Zanivan · 1 shared paper, 2026 · strength 0.28
- Paper Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70213 ↗
Pilar Acedo Núñez · 1 shared paper, 2026 · strength 0.28
- Paper Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70213 ↗
Stephen P. Pereira · 1 shared paper, 2026 · strength 0.28
- Paper Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70213 ↗
Kevin M. Ryan · 1 shared paper, 2026 · strength 0.28
- Paper Identification of serum protein biomarkers for pre-cancerous lesions associated with pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70213 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.